Table 1 -.
Variable | All Patients | CFRT | HFRT |
---|---|---|---|
N = 6490 (100%) | N = 5378 (83%) | N = 1112 (17%) | |
Age (Mean (min, max)) | 75 (40, 90) | 74 (40, 90) | 76 (41, 90) |
BED (Mean (min, max)) | 77.0 (61.4, 112.0) | 77.6 (70.9, 96.0) | 74.3 (61.4, 112.0) |
Miles from hosp (Mean (min, max)) | 18 (0, 2588) | 17 (0, 2420) | 20 (0, 2588) |
Sex (Female vs Male) | 2877 (44%) | 2369 (44%) | 508 (46%) |
Race (White vs Other) | 5566 (86%) | 4618 (86%) | 948 (85%) |
Insurance (Medicare vs Other) | 4934 (76%) | 4069 (76%) | 865 (78%) |
Urban (Pop. >1 million) | 2802 (43%) | 2277 (42%) | 525 (47%) |
Facility Location | |||
1. East Coast | 2570 (40%) | 2089 (39%) | 481 (43%) |
2. Central | 3105 (48%) | 2631 (49%) | 474 (43%) |
3. West Coast | 815 (13%) | 658 (12%) | 157 (14%) |
CDCC_TOTAL | |||
0 | 3817 (59%) | 3178 (59%) | 639 (57%) |
1 | 1709 (26%) | 1411 (26%) | 298 (27%) |
2 | 686 (11%) | 558 (10%) | 128 (12%) |
3 | 278 (4.3%) | 231 (4.3%) | 47 (4.2%) |
Year of Diagnosis >2009 | 2828 (44%) | 2312 (43%) | 516 (46%) |
Tumor location (Upper vs Lower) | 4098 (63%) | 3391 (63%) | 707 (64%) |
Tumor laterality (Right vs Left) | 3825 (59%) | 3162 (59%) | 663 (60%) |
Histology | |||
1. Squamous | 3081 (47%) | 2554 (47%) | 527 (47%) |
2. Adeno | 1754 (27%) | 1461 (27%) | 293 (26%) |
3. Other | 1655 (26%) | 1363 (25%) | 292 (26%) |
Grade | |||
1. Well/mod | 1323 (20%) | 1075 (20%) | 248 (22%) |
2. Poor | 1940 (30%) | 1624 (30%) | 316 (28%) |
3. Not determined | 3227 (50%) | 2679 (50%) | 548 (49%) |
T-stage 3/4 | 3337 (51%) | 2684 (50%) | 653 (59%) |
N-stage 2/3 | 5051 (78%) | 4248 (79%) | 803 (72%) |
Median Income <$38K | 1532 (24%) | 1264 (24%) | 268 (24%) |
Variable | All Patients | CFRT | HFRT |
Continuous variables presented as Mean (Minimum, Maximum). Categorical variables presented as n (%).
HFRT = Hypofractionated Radiotherapy, CFRT = Conventional Radiotherapy, BED = Biologic Effective Dose, HSD = High School Diploma, CDCC = Charlson Deyo Comorbidity Index